Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lipomatosis, Multiple Symmetrical × Hydrocortisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia 8 Prostatic Neoplasms 6 Lymphoma 5 Burkitt Lymphoma 3 Anemia, Refractory, with Excess of Blasts 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Lymphoma, Large-Cell, Anaplastic 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Biphenotypic, Acute 2 Anemia, Refractory 2 Prostate Cancer Metastatic 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lipomatosis, Multiple Symmetrical 1 Lipoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Drug-Related Side Effects and Adverse Reactions 1 Dendritic Cell Sarcoma, Interdigitating 1 Cardiotoxicity 1

Interventions

Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04821583 2021-03-29

N-of-1 SLN

Erasmus Medical Center

Phase 3 Unknown

Lipoma, Lipomatosis, Multiple Symmetrical

Data powered by HemOnc (CC BY 4.0) Colophon ⚡